Predicting the effects of mutations on antibody–antigen binding is a key challenge in therapeutic antibody development. Orders of magnitude more data will be needed to unlock accurate, robust prediction.
- Alissa M. Hummer
- Constantin Schneider
- Charlotte M. Deane